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ABSTRACT
Every day our sensory systems perceive and
integrate a variety of stimuli containing infor-
mation vital for our survival. Pain acts as a
protective warning system, eliciting a response
to remove harmful stimuli; it may also be a
symptom of an illness or present as a disease
itself. There is a growing need for additional
pain-relieving therapies involving the multi-
sensory integration of smell and taste in pain
modulation, an approach that may provide new
strategies for the treatment and management of
pain. While pain, smell, and taste share com-
mon features and are strongly linked to emo-
tion and cognition, their interaction has been
poorly explored. In this review, we provide an
overview of the literature on pain modulation
by olfactory and gustatory substances. It
includes adult human studies investigating
measures of pain threshold, tolerance, intensity,
and/or unpleasantness. Due to the limited
number of studies currently available, we have
structured this review as a narrative in which we
comment on experimentally induced and clin-
ical pain separately on pain–smell and pain–-
taste interaction. Inconsistent study findings
notwithstanding, pain, smell, and taste seem to
interact at both the behavioral and the neural
levels. Pain intensity and unpleasantness seem
to be affected more by olfactory substances,
whereas pain threshold and tolerance are
influenced by gustatory substances. Few pilot
studies to date have investigated these effects in
clinical populations. While the current results
are promising for the future, more evidence is
needed to elucidate the link between the
chemical senses and pain. Doing so has the
potential to improve and develop novel options
for pain treatment.
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There is a need for alternative pain
treatments that do not involve the use of
analgesic drugs.
Research in the last few decades hints at
smell and taste as possibilities for pain
modulation.
This review provides an overview of the
literature on the multisensory integration
of pain, smell, and taste in adults.
Under conditions of experimentally
induced pain, smell and taste substances
seem to have an effect on pain, while
results obtained under clinical conditions
can only be considered preliminary.
More evidence is needed to highlight the
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INTRODUCTION
Pain, smell, and taste are phylogenetically
archaic perceptual systems that have played a
central role in our evolutionary history for sur-
vival [1–3]. Pain is a protective mechanism that
elicits a response to remove harmful stimuli [4],
while smell and taste provide us with mean-
ingful information about food sources in the
environment. While smell helps us process
environmental cues, including danger and
social stimuli [5], taste is more differentiated in
function: sour and salty tastes signal changes in
the body’s pH level and mineral balance; sweet
and umami (savoriness) tastes indicate sources
of energy, while a bitter taste serves as a defense,
alerting us against potentially toxic food and
poisons [6].
By definition, pain is an unpleasant sensory
and emotional experience associated with, or
resembling that associated with, actual or
potential tissue damage [7], occurring in either
acute or chronic form. Acute pain is the
awareness of noxious signaling from recently
damaged tissue, while chronic pain lasts or
recurs for more than 3 months [8]. Pain may
present as a disease in itself or as a symptom of
an underlying condition. Pain can be induced
experimentally and influenced by numerous
factors, such as biological features, other senses,
previous experiences, fears, beliefs, lifestyles,
and affective and cognitive processes [9–11].
Although the neural underpinnings of pain
processing have not yet been completely iden-
tified, painful sensations arise from a complex
network of areas in the brain: mainly the pri-
mary and secondary somatosensory cortices (S1
and S2, respectively), the insula, and the ante-
rior cingulate cortex (ACC). These pain-related
neural areas are commonly referred to as the
pain matrix, although it has been shown that
within this network diverse salient stimuli are
processed [12]. In general, pain is described as a
multidimensional concept. Two different path-
ways carry nociceptive information to the
brain: the anterolateral spinothalamic (con-
nected to the somatosensory cortex and the
lateral thalamus, parietal operculum, and
insula) and the medial spinoreticulothalamic
pathway (connected to the insula, amygdala,
hippocampus, S2, parabrachial nucleus, locus
caeruleus, periaqueductal gray substance, intra-
laminar and medial thalamic nuclei, thalamic
ventral caudal parvocellular nucleus, and ven-
tral caudal portae) [4, 13]. The lateral pathway
conveys sensory-discriminative pain features to
the S1 and the S2, while the medial pathway
conveys affective-motivational pain features to
the insula and the ACC [14, 15]. The former
refers to the spatial, temporal, and qualitative
(intensity) characteristics of pain, while the
latter evokes unpleasantness and triggers a
protective response, thereby highlighting the
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complex nature of pain [4, 16]. These two
dimensions (the sensory-discriminative and the
affective-motivational) form the bases of pain’s
dual nature, and thus the objectivity of pain
cannot be separated from a person’s own
interpretation: they are always integrated in a
person’s evaluation of pain.
Likewise, odors and tastes are often associ-
ated and combined to create flavors [17, 18];
both are closely linked to emotion and cogni-
tion [19, 20]. In the human brain, olfactory
stimuli received by the olfactory bulb and
without a thalamic relay are centrally processed
in the piriform cortex, the amygdala, and the
orbitofrontal cortex [21, 22]. Gustatory stimuli,
relayed by the thalamus, are processed in the
insula, the operculum, and the orbitofrontal
cortex [23, 24].
There is growing evidence for common
neural correlates between pain and chemical
senses in the ACC, the amygdala, and the
orbitofrontal cortex, three areas implicated in
the reward system and motivational behavior in
addition to their involvement in pain percep-
tion and emotional processing [25–29]. For
these reasons, and given that our everyday life is
deeply immersed in a stimuli-rich environment
that we perceive altogether [30], painful, olfac-
tory, and gustatory stimuli interact on several
levels and modulate each other.
Studies carried out in the last two decades
have investigated the relationship between
diverse olfactory–gustatory stimuli and pain
perception and the mechanisms underlying
these effects. This interaction is, however, not
well documented. In this review, we provide a
comprehensive description of studies that have
investigated the modulation of pain through
the use of smell and taste substances, with dif-
ferent paradigms, under both experimental and
pathological pain conditions, and of studies on
painful clinical procedures in adults.
METHODS
A literature search of the PubMed and Scopus
electronic databases was performed indepen-
dently by three of the authors (AS, AZ, RN). An
advanced search in PubMed used the terms
(‘‘Pain’’ [MeSH] OR ‘‘Pain perception’’ [MeSH]
OR ‘‘Analgesia’’ [MeSH]) AND (‘‘Smell’’ [MeSH])
OR ‘‘Odorants’’ [MeSH] OR (‘‘Taste’’ [MeSH]) OR
(‘‘Taste perception’’ [MeSH]); in Scopus, the
advanced search used the terms (‘‘Pain’’ OR
‘‘Analgesia’’ OR ‘‘Pain perception’’) AND
(‘‘Smell’’ OR ‘‘Odorants’’ OR ‘‘Odors’’) OR
(‘‘Taste’’ OR ‘‘Taste perception’’). The search was
limited to articles published up to 20 August
2020. The titles and abstracts were screened
against the following predefined inclusion cri-
teria: (1) papers published in English; (2)
experimental studies in adult humans (psy-
chophysical, neurophysiological, and neu-
roimaging; either clinical populations or
healthy volunteers); and (3) investigation of
pain measures (threshold, tolerance, intensity,
or unpleasantness).Full-text articles were
screened for eligibility.
This review is based on previously con-
ducted studies and does not contain any new
studies performed by any of the authors and
involving human participants or animals.
RESULTS
A total of 2404 potentially relevant articles were
retrieved in the primary literature search, of
which 2373 were excluded because they did not
meet the inclusion criteria based on title/ab-
stract screening (Fig. 1). The full text of the
remaining studies was read, and ultimately 30
studies were included in this review (Tables 1, 2)
[32–61]. A narrative review was chosen due to
differences in study methodologies that made
comparison across studies difficult. For exam-
ple, studies varied by population studied (clini-
cal populations, healthy adults), outcome
measures (studies often investigated only one or
two pain measures), and methodology to
induce pain in healthy population experiments.
Prior to reviewing the literature, we briefly
describe the methods that were used to induce
experimental pain, stimulate the olfactory and
gustatory senses, and measure the outcome,
with the aim to guide readers in understanding
the varied methodologies used in current
research. The results for experimentally induced
and clinical pain are summarized by pain–smell
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and pain–taste interactions separately. We dis-
cuss the results in relation to related papers and
direct the reader to reviews that support inter-
actions of the sort. To conclude, we summarize
the state of the art and highlight the limits and
gaps that need to be filled by future research in
this field.
Experimental Pain: How to Induce
and Measure Pain
Pain can be experimentally elicited by applying
physical, chemical, mechanical, and thermal
stimuli. Hot or cold water induces a painful
sensation lasting several seconds to a few min-
utes. The temperature for hot thermal
stimulation is usually set at 45–50 C, then
adjusted to a participant’s sensitivity [32]. In
experimental settings of cold water stimulation,
namely, the cold pressor test (CPT) or its variant
(ice), the water temperature is usually set at
0–10 C [36, 38, 50–56, 61]. Heat and electrical
stimuli can also be applied to induce pain. Heat
stimuli are delivered by a contact thermode
stimulator attached directly to the skin
[33, 34, 39, 58]. Electrical stimuli are delivered
by electrodes connected to an electrophysio-
logical amplifier and stimulator (digitimer or
digital stimulator) [42, 43, 46]. In both cases,
the stimuli can be delivered in a single pulse or a
train of consecutive pulses. A physical test
which induces pain is the submaximal effort






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































tourniquet test [62] which induces ischemic
pain. In this test, a subject raises his arm above
the heart, and circulation is occluded with a
blood pressure cuff; after lowering his arm, the
subject performs hand-grip exercises [34]. In
another type of physical test, a grade pressure
algometer is used to induce pressure or
mechanical pain by gradually increasing com-
pressive force at a constant rate of grams per
second [34, 35, 49, 61]. Hypertonic saline can
also be injected to elicit muscle pain into the
deep masseter muscle [58]. Exposure to cap-
saicin is a chemical method used to induce
pain. Capsaicin, a natural component of chili
peppers, produces a chemesthetic burning sen-
sation that stimulates a subset of polymodal C
and Ad nociceptive fibers [63], mimicking
symptoms observed in chronic neuropathic
pain [64]. Capsaicin can generate both periph-
eral and central hypersensitivity, as well as
activate pain-sensing afferents and induce cen-
tral sensitization. It is used as a pain model of
excitatory and inhibitory effects in animals and
humans [65–67]. Finally, many odorants can
stimulate the trigeminal nerve, triggering
diverse sensations as burning, cooling, and
stinging pain [68].
Pain measures can be recorded and catego-
rized either quantitatively (use of a device to
measure units in a discrete system, such as
temperature or time) or qualitatively (asking
participants to rate their subjective experience).
This distinction between quantitative and
qualitative measures serves to simplify the
experimental results. A quantitative measure-
ment can be used to assess the pain threshold
and tolerance to pain. The pain threshold refers
to the intensity of the stimulation at which a
subject reports a change in sensation from
painless to slightly painful that identifies the
sensory-discriminative component of pain. In
contrast, pain tolerance refers to the intensity of
stimulation at which a subject reports an
intolerable painful sensation that identifies the
affective-cognitive component of pain [69].
Qualitative measures are based on a partici-
pant’s subjective rating on a visual (VAS) or a
numerical scale (NRS) of pain intensity (the
sensory-discriminative dimension) and
unpleasantness (the affective dimension) [70].
Olfactory-Gustatory Stimulation in Pain
Experiments
Chemosensory stimulation can be delivered by
various methods. There is an ample body of
literature available on the administration of
smell and taste substances (e.g., functional
magnetic resonance imaging [fMRI], olfac-
tory/gustatory event-related potentials). One of
the most commonly used devices to deliver
odors is the olfactometer: subjects inhale odors
through a nasal canula inserted in the nose
[33, 37, 39, 41, 42, 46, 48]. When substances are
delivered via a diffuser or humidifier in the
testing room [34, 36, 40], participants are not
always aware of the stimulation. Another way to
deliver stimuli is by placing essences on cotton
balls/pads [32, 38, 44, 45] or on litmus strips
[43] or by diluting them in a solvent
[33, 37, 39, 42] kept in airtight bottles or fas-
tened inside an air-permeable mask. Finally, a
pen-like odor-dispensing device can be used,
which works with a tampon imbibed with a
liquid odorant or an odorant substance dis-
solved in a solution [47]. In gustatory stimula-
tion, subjects are asked to ingest or to retain
either something solid [49, 55, 58, 61] or a liq-
uid substance in their mouth [50–54, 56, 59, 60]
after drinking from a cup or exposure to a liquid
spray [46, 48].
Subjects are asked to evaluate smell and taste
substances by indicating on a scale (VAS, NRS)
how much they liked (or disliked) a substance
or their mood perception after olfactory stimu-
lation. This can be done in a pilot study phase
to select a preferred/disliked substance for each
participant (for example [32, 33]) or to choose
the substances or the optimal concentration in
experiments later involving a different pool of
participants [36, 38, 40]. Alternatively, evalua-
tion may take place after a substance is admin-
istered to determine whether it was perceived as
intended [43, 46, 48].
Researchers have often been found to fail to
check study participants’ perceptual status of
smell and taste. Few studies have reported that
subjects had been screened with either validated
tests [43, 46–48, 57] or an experimental para-
digm devised to detect gross dysfunction in
their perception of the stimuli [33, 39, 42].
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Some studies simply asked subjects to self-report
their history of smell or taste dysfunction that
would exclude them from participation




Research on the smell–pain interaction in
healthy adults has used a variety of method-
ologies and odors, making it difficult to com-
pare findings across studies. Most studies to date
were focused on qualitative pain measures (in-
tensity and unpleasantness), while only a few
explored the pain threshold and/or pain toler-
ance. Reporting of qualitative pain measures of
pain intensity has sometimes been inconsistent.
For example, pain intensity was reportedly not
modified by odors in studies in which pain was
induced by hot or cold thermal stimulation
[33, 38, 39] or with capsaicin cream applied to
the back of the right hand at the level of the first
dorsal interosseous muscle [48] or with phasic
nicotine stimuli to induce burning and stinging
pain [41]. One study applied three different
modes of stimulation (thermode, pressure
algometer, ischemic) and reported reduced pain
intensity associated with essential oil of laven-
der only in men [34]. Another study reported a
reduction in pain intensity following thermal
stimulation of around 46–48 C only in women
when the most pleasant odor selected for each
participant was delivered [32]. Pain intensity
was reported to be increased with the delivery of
an unpleasant odor of machine oil (selected in a
pilot study) at the CPT [36], while other studies,
by means of electrical stimuli, reported that
pain intensity decreased and increased with the
delivery of pleasant (vanillin) and unpleasant
(N-valeric acid) odors, respectively [42], and
decreased with lavender oil [43]. More recently,
these findings were confirmed in a study
applying electrical stimulation and delivering
the pleasant odor (banana), whereas no effect
was found for the unpleasant odor (fish) [46].
Studies have reported convergent results for
the effect of odors on modulating pain
unpleasantness: pain unpleasantness evoked by
painful stimuli was reduced by pleasant odors
and/or increased by unpleasant odors
[32, 34, 43, 46, 48]. These observations are
shared by Villemure and collaborators [33, 39],
who reported a strong connection between pain
response and subjects’ mood. These authors
showed that the pleasant odor induced a posi-
tive mood and decreased pain-related activity
within the ACC, the medial thalamus, the S1,
and the S2 [39].
Two studies in quantitative pain assessment
reported that the pain threshold for electrical,
thermode, pressure algometer and ischemic
stimulation was not modified by odors [34, 46].
Only one study found that mechanical painful
stimulation was modified at the pain threshold
by a ‘‘green’’ odor, but information on the
number of subjects tested and the experimental
design were not available [35]. In contrast, pain
tolerance was significantly longer in the sweet-
smelling condition at the CPT [38], but not with
the use of other painful stimuli (electrical,
thermode, pressure algometer stimulation,
ischemic procedure) [34, 46].
Interplay Between Taste and Experimental
Pain
The majority of studies that have investigated
the pain–taste interaction to date induced pain
with the CPT and administered sweet sub-
stances. Several focused on pain threshold and
tolerance, while a few evaluated the qualitative
measures of pain. Pain threshold at the CPT was
found to be increased in adult males when the
subjects held sugar diluted in water or sugar
tablets in their mouth [53, 55, 56, 59]. The pain
threshold was also increased by spicy and sweet
stimulation at the CPT and the pressure
algometer [61]. Other studies found no effect of
sugar preparations on the pain threshold as
measured with the CPT [50, 51] or with a pres-
sure algometer and sweet soft drinks and
palatable food [49]. Bitter and sweet tastes were
found to have no effect on the pain threshold
measured with thermal stimulation [58]. Recent
studies using electrical stimulation have repor-
ted no change in the pain threshold after the
administration of sweet and bitter substances
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[46]; similarly, no change in pain threshold was
recorded after heat thermal stimulation and the
administration of sweet substances [60].
Pain tolerance was found to be increased by
sugar at the CPT [50, 54, 59], also when the
algometer pressure test was used together with
the administration of palatable food-but only
in women [49]. Nevertheless, no effect on pain
tolerance was found at the CPT or after applying
either electrical or thermal stimulation
[46, 51, 53, 56, 58].
None of the studies investigating the quali-
tative measures of pain reported an effect of
taste on pain intensity
[46, 48–50, 52–54, 56, 58, 60]. Furthermore,
pain unpleasantness was not influenced by taste
as measured with a pressure algometer [49], the
CPT [50–52] or application of a capsaicin cream
[48]. In one study evaluating phasic pain
evoked by brief electrical skin stimuli, pain
unpleasantness was reduced with the adminis-
tration of a sucrose solution [46].
Only one study in healthy adults explored
the interaction between pain and taste at the
central level. Pain-related neural networks (e.g.,
ACC, insula, posterior parietal cortex, thalamus)
can be activated by the CPT, and this activation
was found to be reduced in the sweet taste
condition [55].
The Influence of Smell and Taste in Pain
in Pathological Conditions
A major area of health care concerns illness-re-
lated pain, and many diseases are the causes of
pain (e.g., cancer, neurological and dental dis-
ease). The pharmaceutical industry is a major
driver of research on and the development of
analgesic drugs, concomitant with the search
for new and alternative treatments [9, 71].
Moreover, complementary treatments are nee-
ded to make routine painful healthcare proce-
dures more sustainable. Few studies to date have
directly investigated the effect of smell and taste
on the modulation of pain.
Smell and Pain
Certain types of odors encountered in daily life
can exacerbate neuropathic pain, as noted in a
patient with neuropathic pain secondary to
cervical myelopathy of unclear origin, most
often affecting the right hand, wrist, and elbow
but also the hip and spine [37]. When tested
with unpleasant and pleasant odors, the patient
rated pain intensity and unpleasantness
according to the valence of the odors. More-
over, evidence from fMRI revealed increased
activation in pain processing areas (e.g., thala-
mus, amygdala, insular cortex, ACC) when the
patient was exposed to an unpleasant odor.
In a recent study, a 4-week olfactory training
program was evaluated in patients with chronic
low back pain [47]. Post-training results showed
a higher pain threshold during electrical cuta-
neous stimulation, suggesting that olfactory
training might be useful in desensitizing pain
perception circuits.
The pain intensity of patients attending
dental clinics was found not to be affected by
orange and apple odors [40]. Pain intensity was
however decreased after needle insertion in
patients with end-stage chronic renal failure
[44] and in pregnant women in labor [45], both
with the use of essential lavender oil.
Taste and Pain
Only one study has directly explored pain
modulation through taste: lower pain intensity
scores immediately after sucralose administra-
tion were recorded in three patients with
burning mouth syndrome (BMS) [57].
DISCUSSION
Pain–Smell Interaction
Findings of a pain–smell interaction in experi-
mental pain models underline the effect of
odors on the qualitative measures of pain
[32–34, 36, 39, 42, 43, 46, 48]. There is growing
body of evidence supporting the neurobiologi-
cal role of olfaction. Olfaction has been linked
to depression [72] and odor sensitivity has been
associated with personality traits [73], indicat-
ing a strong connection to the affective domain.
Olfactory substances are known to exert bene-
ficial effects on physiological and psychological
processes in animals and humans alike [74–76].
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On one study, chemical stimuli was found to
activate the olfactory and the trigeminal system
[41]. In the same study, although nicotine
burning and stinging painful sensations were
not altered by menthol, a nicotine effect on
menthol concentrations was noted, with the
highest nicotine concentration eliminating
participants’ ability to discriminate the men-
thol concentrations for odor intensity and
cooling [41]. Moreover, carbon dioxide (CO2)
can elicit trigeminal painful perception: sub-
jects with a higher sensitivity to CO2 pain
thresholds (women and older participants) were
found to score better in odor identification [68].
Exposure to various intensities of these stimuli
demonstrated the primary role of the S2 and the
piriform cortex in coding subjectively perceived
intensity of intranasal trigeminal stimuli [77]
and how trigeminal and smell painful sensa-
tions can interact at the peripheral and the
central level, suggesting a strong connection
between the senses. These observations are in
agreement with imaging findings that showed
decreasing pain-related activity within the ACC,
the medial thalamus, the S1, and the S2 after
the administration of a pleasant odor [39].
Taken together, the results suggest an effective
modulatory role for odors in nociception,
especially the effect of smell on the affective
dimension of pain.
Studies on quantitative measures of pain and
smell are few and the results are inconsistent
[34, 35, 38, 46]. While only two studies have
reported an effect of smell on pain threshold
and pain tolerance, respectively [35, 38], an
effect of pleasant and unpleasant odors on the
magnitude of the nociceptive withdrawal reflex
(NWR) was reported in another study [42]. The
NWR is the electromyographical (EMG)
response recorded in the biceps femoris at
80–150 ms (RIII) after electrical stimulation of
the sural nerve corresponding to a nociceptive
reflex [69]. Bartolo and collaborators [42] found
the reflex magnitude to be reduced by the
pleasant odor and increased by the unpleasant
odor during constant electrical stimulation at a
fixed intensity. To our knowledge, these are the
only findings for an effect of odors on a defense
response mediated by acute spinal nociception
in humans. More research using quantitative
measures is needed to clarify the regulatory role
of olfaction.
In summary, the few human studies con-
ducted to date in this area indicate that the pain
threshold and pain tolerance for most types of
painful stimulation are not significantly modi-
fied by odors. However, odors do seem to
influence the qualitative measures of pain in
response to a variety of painful stimuli. Mostly,
pleasant odors reduce pain unpleasantness
while unpleasant odors increase it. This differ-
ence may be related to mood and activation of
the ACC, the medial thalamus, and the
somatosensory cortices.
Pain–Taste Interaction
The results of experimental studies on pain
threshold and tolerance in pain–taste interac-
tion are inconsistent, although the majority of
studies reported at least an effect on one of
those measures [49, 50, 52–56, 59, 61]. Some
studies reported a gender effect, with an effect
of taste on the pain threshold and/or pain tol-
erance in men [53–56, 59] but no effect on the
pain threshold in women [49, 51, 60]. One
study explored gender differences by means of
the CPT and found an effect of sweet substances
on the pain threshold but not on pain tolerance
[56]. This observation is partially shared by
another study that reported an effect of the
nociceptive flexion reflex [78]. Despite the small
sample size of this latter study, the analgesic
effect of sucrose after electrical stimulation was
found to be shorter in women (\ 10 min) but
longer in men (up to 15–20 min) [78]. An effect
on pain tolerance with palatable food among
the women was found using the algometer
pressure test [49]. More research is needed to
better explore these gender-related differences.
No effect on pain intensity has been found
after taste stimulation
[46, 48–50, 52–54, 56, 58, 60], but a positive
correlation was found between pain intensity
and intensity of bitter taste perception, as eli-
cited by the CPT and the PROP (6-n-propy-
thiouracil) papers test: the subjects who
perceived the more intense pain perceived the
bitter taste as more intense [79].
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To date, nearly all studies exploring experi-
mental pain–taste interaction used sweet sub-
stances. A few administered a quinine
hydrochloride solution to induce a bitter taste
but no effect on the pain measurement was
elicited [46, 48, 50, 58]. The question of whe-
ther bitter substances tend to increase pain
perception (like an unpleasant smell does)
remains unanswered.
Taste is involved in the oral perception of
food and derived chemicals, which allows us to
recognize potentially harmful and healthy
foods [80]. Taste anatomy is complex: cranial
nerve (CN) VII, CN IX, and CN X carry gusta-
tory information, each from a specific area [81].
The five common tastes (sweet, salty, sour, bit-
ter, umami) are usually perceived in combina-
tion with one another while eating food. We
experience a complex sensation from smell plus
taste (flavor) and activation of the trigeminal
and glossopharyngeal nerves (i.e., chemesthe-
sis), which in turn generates pungency or irri-
tation [18, 82]. Chemesthesis and painful
sensations are merged and mediated by tran-
sient receptor potential (TRP) channels that
detect visceral pain and taste, highlighting the
role they play in sensory nervous systems and
their wide range of sensory capacities [83, 84].
A subset of gustatory fibers can be stimulated
by capsaicin in the mouth: lower capsaicin
concentrations have been identified in adults as
a basic taste, especially bitter [85]. In one study,
the burning sensation elicited by capsaicin was
misidentified as bitter taste on a discrimination
task, with the subjects identifying bitter and
capsaicin as perceptually similar on a similarity/
dissimilarity scale compared to other basic
tastes [86]. This qualitative similarity between
bitter taste and capsaicin suggests a common
function as sensory signals of potentially
harmful stimuli of these two sensations. Cap-
saicin can also be used as a prototypical stimu-
lus to induce pain in the oral cavity, where it
induces a burning and painful sensation that
activates both taste and trigeminal nerve fibers.
Sucrose can reduce the burning sensation in the
mouth induced by the oral application of cap-
saicin in healthy subjects [87]. Similarly, other
compounds, such as menthol, seem to exert an
analgesic countereffect on capsaicin [88] and on
the irritant intensity of nicotine [89]. In con-
trast, a spicy stimulation can increase the pain
threshold at the CPT and pressure pain,
appearing to have analgesic effects similar to
sweet stimulation [61]. These results reveal how
trigeminal pain and taste sensations interact
with different modalities at the peripheral level.
Another limitation in the pain–taste inter-
action is that almost all studies administered
sucrose and induced pain with the CPT. Differ-
ences in the procedures may explain differences
in the results: the temperature at which the CPT
was conducted (range 0–2 C to 10 C) or the
experimental design (some experiments per-
formed on different days, others all in one ses-
sion). Only a few studies used different methods
[46, 48, 49, 58, 60, 61].
A future area of focus would be to test other
basic tastes besides sweetness and a variety of
palatable foods, as was done by two studies
[49, 61], which is well documented in rats
[90–92]. Food is a strong reward: in one study,
substances (palatable food) similar to others
that modulate pain tolerance [49] were used to
investigate the enjoyment, pleasantness, and
taste intensity of food after the presence or
absence of a painful situation (i.e., CPT) [93].
The authors reported that the palatable food
was rated as more enjoyable and more intense
and that the flavors were named quicker after
the pain condition [93]. The relationship
between pain and taste seems to be bidirec-
tional: not only can taste affect a painful expe-
rience but nociceptive sensations can impact on
taste perception.
Finally, one study reported that the sweet
taste condition reduced pain-related neural
networks (e.g., ACC, insula, posterior parietal
cortex, thalamus) activated by the CPT [55].
This network partly overlaps with situations of
induced pain and smell in healthy subjects [39].
The brain areas modulated by olfactants were
the ACC, the medial thalamus, the S1, and the
S2. More research into these networks is needed.
Studies on the role of the ACC in the interaction
between pain, smell, and taste have postulated
the central involvement of this area in emo-
tional processing and pain perception [27, 42].
The role of the thalamus has not yet been elu-
cidated although recent evidence suggests that
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it may be involved in mental integration and
regulation and not just function as a point of
relay [94].
Taken together, these findings underline
that common substrates may influence the
integration of inputs from different sensory
systems. However, the results of the studies
conducted to date are often contradictory and
less robust than those from studies exploring
the link between pain and smell. The pain
threshold and tolerance for painful stimuli are
modulated by taste substances, but pain inten-
sity is not. No firm conclusion can be drawn on
pain unpleasantness because of the paucity of
studies exploring this measure of the affective
component of pain.
Interaction Pain–Smell in Pathological
Conditions
It is notoriously difficult to treat pain in the
context of an illness. However, using experi-
mental pain models, researchers can simulate
clinical conditions and investigate pain in a
meaningful context. There is mounting evi-
dence supporting a modulatory effect of smell
and taste on pain in healthy subjects, laying the
basis for research into pain conditions.
The few published studies that have explored
the interaction between pain and smell in
clinical conditions can be considered to be
preliminary, although the neuroimaging find-
ings in one patient (increased activation of
thalamus, amygdala, insular cortex, ACC with
unpleasant odor) [37] highlight the existence of
common neural areas shared by pain and
chemical sensation [26–29, 42]. These results
are consistent with those found in healthy
subjects (both behavioral and with fMRI)
[33, 39], with the exception that the related
activated network involved the ACC, the medial
thalamus, the S1, and the S2 [39]. This differ-
ence in activation pattern may have been due to
the kind of pain and the odors administered.
Specifically, the patient was tested with pyr-
idine (unpleasant and known to increase pain)
and aquaflore (evoking little or no change in
pain perception), while the healthy subjects
were tested with the odors they liked or disliked
most. Neuroimaging studies are needed to cor-
roborate these results, although the chronic use
of analgesics can lead to reduced perception of
intranasal trigeminal stimuli and olfactory
function [95], again suggesting multisensory
interaction at the central level. Abnormalities of
the limbic system have also been suggested,
involving olfactory and pain processing, by a
study investigating odor identification and
pain-related somatosensory-evoked potentials
(SEPs) electrically stimulated on the faces of
patients with Parkinson’s disease (PD) [96]. A
positive correlation was found between the
amplitude of the SEPs and smell identification
scores (the higher the olfactory score, the
greater the pain-related SEP amplitude).
The pilot study reporting a change in pain
threshold after olfactory training [47] adds to the
evidence from a previous clinical case report on
chronic pain in a woman with a 10-year history of
burning pain in both feet and abdominal pain
attacks and odor hypersensitivity who experi-
enced short-term pain relief after continuous odor
exposure training [97]. Genetic analysis revealed a
mutation within the SCN9A gene encoding volt-
age-gated sodium channel [Na(v)1.7] with gain-
of-function in olfactory and pain sensation. Loss
of function of the channel altered pain percep-
tion and olfaction acuity [98], demonstrating a
strong neurobiological link between pain and
smell. Studies have reported a congenital inability
to experience pain accompanied by anosmia in
mice and humans [99–101], and lower respon-
siveness to CO2 pain stimuli in patients with
olfactory loss [68].
In three other studies, apple and orange
odors [40] were used in one and lavender oil was
applied in two [44, 45]. An effect on pain
intensity was reported only by the studies that
applied lavender oil [44, 45]. Widely applied in
aromatherapy, lavender oil can reduce migraine
headache severity [102]. In one case report,
migraine attacks triggered by the smell of
onions and garlic were relieved by inhalation of
peppermint oil [103]. Odors are known to trig-
ger migraine attacks; studies have found atro-
phy of the olfactory bulb in migraine patients
[104] and increased activity in response to
olfactory stimulation in the brain areas (piri-
form, insular and orbitofrontal cortices,
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amygdala, hippocampus) [105] that process
pain and chemical sensation, showing, once
again, a link at the neural level.
There are contradictory results for aro-
matherapy by inhalation (e.g., do they provide
relief and comfort and reduce stress?) although
an extensive body of research exists on clinical
procedural pain in infants and its relation with
smell [106–110]. Aromatherapy may therefore
have an effect on pain intensity modulation
and be a useful treatment in clinical practice.
Taken together and in line with results from
healthy subjects, these clinical findings high-
light behavioral and neural interactions
between pain and smell. Odors can alter pain
perception, with a differential effect on pain-
related areas involved in processing the emo-
tional aspects of pain. The inhalation of essen-
tial oils may be a useful means to manage pain
when combined with conventional treatments.
These recent findings hold promise for the use
of odors in pain management [47], although
more research is needed.
Interaction Pain–Taste in Pathological
Conditions
The interaction between pain and taste sensa-
tion in adults has been little studied to date,
with only one study reporting on pain–taste
interaction in clinical conditions; although
preliminary, the findings are of interest [57].
BMS is an unusual idiopathic condition in
which pain and taste disturbances are often
linked. The oral pain is not caused by a clini-
cally evident lesion (International Classification




quent complaints are taste disturbances, par-
ticularly bitter or metallic phantom tastes, and
dysgeusia [111–115]. Various study results hint
at peripheral dysfunction [111, 113–117],
whereas other findings account for changes in
the pain matrix, suggesting a deficit in the
central organization of pain [118].
An interaction between taste and pain per-
ception may arise from injury to the nerves
carrying gustatory information. Damage to the
facial nerve (CN VII) at the chorda tympani can
cause abnormal pain and taste sensation, often
occurring together [119]. The chorda tympani
nerve is an important branch of the facial nerve;
it conveys gustatory information from the
anterior two-thirds of the tongue, and together
with the lingual branch of the trigeminal nerve
(CN V) it transmits lingual somatosensory sig-
nals (e.g., pain, temperature, touch) [120].
Patients with nerve damage report that a sour or
bitter taste can cause unbearable pain and an
oral phantom (metallic, bitter, salty) sensation:
the greater the taste loss, the greater the pain
experienced, including extra-oral pain [119].
Also, unilateral damage to a single chorda
tympani nerve can increase contralateral non-
taste oral sensation, including oral burning
produced by capsaicin [87]. There is evidence
for intertalk between the chorda tympani (CN
VII) and the trigeminus (CN V) [121, 122]. In
addition, a central interaction was found in
patients with chronic back pain who were more
sensitive to detecting citric acid solutions and
rated bitter and salty solutions more intense
than healthy controls [27].
As per the pain–smell interaction, a consis-
tent line of research exists in children and taste
during painful procedures [123–128]. Summa-
rizing, these findings point towards an interac-
tion between pain and taste during clinical
procedures, at least at the peripheral level,
which need to be largely explored in adults.
CONCLUSION
The main findings of this review are that odors
may alter the qualitative components of pain,
especially pain unpleasantness, as shown by the
higher scores for unpleasant odors and the
lower scores for pleasant odors. This effect has
been consistently reported in healthy subjects
[32–34, 36, 39, 42, 43, 46, 48], and the results in
pain management are promising [37]. Very
recent preliminary results show a considerably
higher pain threshold in persons with chronic
low back pain after olfactory training and the
benefit of regular use of odors as an adjunct in
pain management [47]. Consistent with this
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approach, aromatherapy is beginning to gain a
place in the complementary management of
clinical pain [44, 45]. These findings are sup-
ported by neuroimaging studies that show the
involvement of a network of brain areas related
to the affective dimension of pain (e.g., ACC
and thalamus) [37, 39]. Such results are to be
considered preliminary, given the absence of a
control condition versus substance administra-
tion and the fact that in the clinical pain
experiment only a single patient was tested.
In comparison, research results are few and
less consistent for taste. In experimental pain
models, sweet substances appear to modulate
the quantitative measures of pain
[49, 50, 52–56, 59, 61] while qualitative mea-
sures documented no effect on pain in healthy
adults, with the exception of one study that
reported lower ratings of pain unpleasantness
with a sweet substance in comparison with a
bitter one [46]. Sucralose has been shown to
modulate pain intensity in the context of pain
in illness [57], although this was a pilot study
involving only three patients. Future studies
will need to better assess the effect of taste
substances in experiments on populations sub-
ject to induced pain and clinical pain, with the
inclusion of other basic tastes and more com-
plex substances to gain a more comprehensive
understanding of such interactions. The mod-
ulation of pain by a sweet taste seems to involve
the ACC, the thalamus, and other brain areas in
healthy adults [55]. This type of evidence needs
to be confirmed by functional imaging studies
and also in comparative studies with olfactory
substances to identify the common neural areas
shared by pain, smell, and taste. Finally,
potential gender-related differences should be
explored, taking into account that the findings
in studies on the pain–taste interaction reveal
an effect on pain threshold in men [56] and on
pain tolerance in women [49], and the lack of
studies investigating the pain–smell interac-
tion. Summarizing, pain, smell, and taste seem
to interact at both the peripheral and the cen-
tral level, but additional evidence is needed to
fill the present knowledge gaps. The use of dif-
ferent methodologies can extend the results to
different pain experiences, but better high-
quality procedures will be needed for future
research. While we do not suggest the use of
complementary therapy to analgesics, the
research lines reviewed here open new avenues
in pain management and improved quality of
life of patients with pain. Just as smell and taste
are rarely experienced separately but rather
together as flavors, so, too, pain is often a much
more complex emotional experience in real life.
Current Limitations and Future
Perspectives
The main limitation in this field is that few pilot
studies have investigated the effect of odor and
taste on clinical populations with different
types of pain. The results presented here provide
a basis for future studies to elucidate the link
between the chemical senses and pain. Multi-
center studies applying the same experimental
paradigm to larger samples of patients with
different pain conditions could lead to the dis-
covery of novel options to pain treatment.
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77. Lötsch J, Oertel BG, Felden L, et al. Central encod-
ing of the strength of intranasal chemosensory
trigeminal stimuli in a human experimental pain
setting. Hum Brain Mapp. 2020;41:5240–54.
78. Bhattacharjee M, Bhatia R, Mathur R. Gender
specificity of sucrose induced analgesia in human
adults. Indian J Physiol Pharmacol. 2007;51(4):
410–4.
79. Perkins M, de Bruyne M, Giummarra MJ. A pain in
the bud? Implications of cross-modal sensitivity for
pain experience. Atten Percept Psychophys.
2016;78:2348–56.
80. Breslin PAS. An evolutionary perspective on food
and human taste. Curr Biol. 2013;23(9):R409–18.
81. Cecchini MP, Fasano A, Boschi F, Osculati F, Tinazzi
M. Taste in Parkinson’s disease. J Neurol. 2015;262:
806–13.
82. Auvray M, Spence C. The multisensory perception
of flavor. Conscious Cogn. 2008;17(3):1016–31.
83. Aroke EN, Powell-Roach KL, Jaime-Lara RB, et al.
Taste the pain: the role of TRP channels in pain and
taste perception. Int J Mol Sci. 2020;21:5929.
84. Green BG, Schullery MT. Stimulation of bitterness
by capsaicin and menthol: differences between lin-
gual areas innervated by the glossopharyngeal and
chorda tympani nerves. Chem Senses. 2003;28:
45–55.
85. Just T, Pau HW, Steiner S, Hummel T. Assessment of
oral trigeminal sensitivity in humans. Eur Arch
Otorhinolaryngol. 2007;264:545–51.
86. Lim J, Green BG. The psychophysical relationship
between bitter taste and burning sensation: evi-
dence of qualitative similarity. Chem Senses.
2007;32:31–9.
87. Schöbel N, Kyereme J, Minovi A, Dazert S, Bar-
toshuk L, Hatt H. Sweet taste and chorda tympani
transection alter capsaicin-induced lingual pain
perception in adult human subjects. Physiol Behav.
2012;107:368–73.
88. Green BG, McAuliffe BL. Menthol desensitization of
capsaicin irritation: evidence of a short-term anti-
nociceptive effect. Physiol Behav. 2000;68:631–9.
89. Dessirier JM, O’Mahony M, Carstens E. Oral irritant
properties of menthol sensitizing and desensitizing
effects of repeated application and cross-desensiti-
zation to nicotine. Physiol Behav. 2001;73:25–36.
90. Foo H, Mason P. Sensory suppression during feed-
ing. Proc Natl Acad Sci USA. 2005;102(46):16865–9.
91. Foo H, Crabtree K, Thrasher A, Mason P. Eating is a
protected behavior even in the face of persistent
pain in male rats. Physiol Behav. 2009;97(3–4):
426–9.
92. Foo H, Mason P. Analgesia accompanying food
consumption requires ingestion of hedonic foods.
J Neurosci. 2009;29(41):13053–62.
93. Bastian B, Jetten J, Hornsey M. Gustatory pleasure
and pain. The offset of acute physical pain enhances
responsiveness to taste. Appetite. 2014;72:150–5.
94. Wolff M, Vann SD. The cognitive thalamus as a
gateway to mental representations. J Neurosci.
2019;39(19):3–14.
95. Mizera L, Gossrau G, Hummel T, Haehner A. Effects
of analgesics on olfactory function and the percep-
tion of intranasal trigeminal stimuli. Eur J Pain.
2017;21:92–100.
96. Hara T, Hirayama M, Mizutani Y, et al. Impaired
pain processing in Parkinson’s disease and its rela-
tive association with the sense of smell. Parkinson-
ism Relat Disord. 2013;19:43–6.
97. Haehner A, Hummel T, Heinritz W, et al. Mutation
in Nav1.7 causes high olfactory sensitivity. Eur J
Pain. 2018;22:1767–73.
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